Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:BCT CVE:KNE CVE:RVV CVE:SVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCTBriaCell TherapeuticsC$10.60-3.8%C$10.60C$3.50▼C$15.75C$168.68MN/A12,671 shs3,402 shsKNEKane BiotechC$0.05+12.5%C$0.05C$0.04▼C$0.16C$6.48M0.5273,836 shs157,001 shsRVVRevive TherapeuticsC$0.08+14.3%C$0.08C$0.07▼C$0.25C$5.79MN/A93,085 shs212,852 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCTBriaCell Therapeutics0.00%0.00%0.00%0.00%0.00%KNEKane Biotech+12.50%+12.50%0.00%-25.00%-70.00%RVVRevive Therapeutics0.00%0.00%0.00%0.00%0.00%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBCTBriaCell TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/AN/AN/AN/AN/ARVVRevive TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBCTBriaCell Therapeutics 0.00N/AC$15.0041.51% UpsideKNEKane Biotech 0.00N/AN/AN/ARVVRevive Therapeutics 0.00N/AN/AN/ASVSSolarvest BioEnergy 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBCTBriaCell TherapeuticsN/AN/AC$3.34 per share3.17C$3.60 per shareN/AKNEKane BiotechC$1.42M4.55C$0.01 per share8.50C($0.01) per share-8.74RVVRevive TherapeuticsN/AN/AC$0.03 per share3.18C$0.02 per shareN/ASVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBCTBriaCell TherapeuticsN/A-C$0.38N/A∞N/AN/AN/AN/AN/AKNEKane BiotechC$6.03MC$0.041.13∞N/A423.52%-94.49%-58.43%N/ARVVRevive TherapeuticsN/A-C$0.02N/A∞N/AN/AN/AN/AN/ASVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBCTBriaCell TherapeuticsN/AN/AN/AN/AN/AKNEKane BiotechN/A3.08%N/AN/AN/ARVVRevive TherapeuticsN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBCTBriaCell Therapeutics0.05129.63128.68KNEKane Biotech-331.420.800.39RVVRevive TherapeuticsN/A6.146.03SVSSolarvest BioEnergyN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBCTBriaCell TherapeuticsN/AKNEKane BiotechN/ARVVRevive TherapeuticsN/ASVSSolarvest BioEnergyN/AInsider OwnershipCompanyInsider OwnershipBCTBriaCell TherapeuticsN/AKNEKane Biotech37.21%RVVRevive TherapeuticsN/ASVSSolarvest BioEnergy15.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBCTBriaCell Therapeutics515.91 millionN/ANot OptionableKNEKane BiotechN/A144.06 millionN/ANot OptionableRVVRevive TherapeuticsN/A72.41 millionN/ANot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableSVS, RVV, KNE, and BCT HeadlinesRecent News About These CompaniesSolarvest appoints Daniel Ruppert as CIOJuly 16, 2025 | thestar.com.myTSolarvest on track for strong FY26July 15, 2025 | thestar.com.myTSolarvest expands Asean footprint with Brunei’s solar power dealJune 17, 2025 | thestar.com.myTSolarvest to build 30MW solar project, Brunei’s largest PV plant to dateJune 16, 2025 | pv-tech.orgPSolarvest continues to make hay as the sun shinesJune 10, 2025 | thestar.com.myTA Look At The Intrinsic Value Of Solarvest Holdings Berhad (KLSE:SLVEST)May 27, 2025 | finance.yahoo.comSolarvest order book to surpass RM2bil in FY26May 21, 2025 | thestar.com.myTSolarvest optimistic orderbook to surpass RM2bil in FY26May 21, 2025 | thestar.com.myTMIDA Facilitates RM142 Mln Energy Partnership Between Solarvest, HSS & Shizen At Osaka ExpoApril 17, 2025 | bernama.comBWhile private companies own 23% of Solarvest Holdings Berhad (KLSE:SLVEST), individual investors are its largest shareholders with 32% ownershipApril 16, 2025 | finance.yahoo.comSolarvest order book hits record RM1.4bilMarch 27, 2025 | thestar.com.myTSolarvest maintains sunny outlookMarch 27, 2025 | thestar.com.myTSolarvest To Be Prime Beneficiary Of Large-scale Solar Contracts - HLIBMarch 27, 2025 | bernama.comBSolarvest unit wins RM103mil EPCC contractMarch 27, 2025 | thestar.com.myTSolarvest unit secures RM103.08mil EPCC contract for solar PV facility in Pulau PinangMarch 26, 2025 | thestar.com.myTUpbeat outlook for Solarvest on LSS5 plan shortlistMarch 21, 2025 | thestar.com.myTSolarvest subsidiary signs PPA for 60MWac solar PV facilityMarch 19, 2025 | thestar.com.myTSolarvest In Good Position To Capitalise On Malaysia RE Sector Opportunities - Maybank IBMarch 18, 2025 | bernama.comBSolarvest bags EPCC deal valued at RM401milMarch 18, 2025 | thestar.com.myTSolarvest unit bags RM401mil EPCC works project under LSS5March 17, 2025 | thestar.com.myTNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025This Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025Applied Materials' Knee-Jerk Sell-Off Is Your Signal to BuyBy Thomas Hughes | August 15, 2025SVS, RVV, KNE, and BCT Company DescriptionsBriaCell Therapeutics CVE:BCTC$10.60 -0.42 (-3.81%) As of 12/30/2021BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.Kane Biotech CVE:KNEC$0.04 +0.01 (+12.50%) As of 08/15/2025 12:18 PM EasternKane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.Revive Therapeutics CVE:RVVC$0.08 +0.01 (+14.29%) As of 07/22/2019Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.Solarvest BioEnergy CVE:SVSC$0.02 0.00 (0.00%) As of 09/5/2023Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore The Real Reason Ford Stock Is Rallying—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access